Skip to main content

Advertisement

SpringerLink
Log in

Invited commentary

  • Original Scientific Reports
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wilke, H., Preusser, P., Fink, W., et al.: New developments in the treatment of gastric carcinoma. Semin. Oncol.17:61, 1990

    Google Scholar 

  2. Wils, J.A., Klein, H.O., Wagener, D.J.T., et al.: Sequential high-dose methothrexat and FU combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer. J. Clin. Oncol.9:827, 1991

    Google Scholar 

  3. Kelsen, D., Atiq, O.T., Saltz, L., et al.: FAMTx versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. J. Clin. Oncol.10:541, 1992

    Google Scholar 

  4. Schlag, P.: Results of surgery in multimodality therapy of esophageal cancer. Oncologie14:13, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Abdominal und Transplantations Chirurgie Medizinische Hochschule Hannover, FRG

    R. Pichlmayr M.D.

Authors
  1. R. Pichlmayr M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pichlmayr, R. Invited commentary. World J. Surg. 17, 261–262 (1993). https://doi.org/10.1007/BF01658940

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01658940

Keywords

Search

Navigation